0001437749-16-037322.txt : 20160812
0001437749-16-037322.hdr.sgml : 20160812
20160812162125
ACCESSION NUMBER: 0001437749-16-037322
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160811
FILED AS OF DATE: 20160812
DATE AS OF CHANGE: 20160812
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aviragen Therapeutics, Inc.
CENTRAL INDEX KEY: 0000072444
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 591212264
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 2500 NORTHWINDS PARKWAY, SUITE 100
CITY: ALPHARETTA
STATE: 2Q
ZIP: 30009
BUSINESS PHONE: 301-770-3099
MAIL ADDRESS:
STREET 1: 2500 NORTHWINDS PARKWAY, SUITE 100
CITY: ALPHARETTA
STATE: 2Q
ZIP: 30009
FORMER COMPANY:
FORMER CONFORMED NAME: Biota Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20121113
FORMER COMPANY:
FORMER CONFORMED NAME: NABI BIOPHARMACEUTICALS
DATE OF NAME CHANGE: 20100719
FORMER COMPANY:
FORMER CONFORMED NAME: NABI BIOPHARMACEUTICALS
DATE OF NAME CHANGE: 20020304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PATTI JOSEPH M
CENTRAL INDEX KEY: 0001283215
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35285
FILM NUMBER: 161828493
MAIL ADDRESS:
STREET 1: 12270 WILKINS AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20852
4
1
rdgdoc.xml
FORM 4
X0306
4
2016-08-11
0000072444
Aviragen Therapeutics, Inc.
AVIR
0001283215
PATTI JOSEPH M
2500 NORTHWINDS PARKWAY
STE 100
ALPHARETTA
GA
30009
1
1
CEO
Stock Option (Right to Buy)
1.30
2016-08-11
4
A
0
380000
1.30
A
2017-08-11
2026-08-11
Common Stock
380000
1478929
D
The stock option vests in equal annual installments beginning on the first anniversary and thereafter on the second and third anniversary ratably.
/s/ Joseph M. Patti
2016-08-12